BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
Serving our clients is Synteract's number one priority. We understand the many challenges that you may face with your clinical trials and will help you meet those challenges effectively. We also understand that you may have constraints. We can work within them: meeting your timelines, utilizing your standards, adapting to your needs, and most importantly, being there when you need us. We make your goals our goals. Our people are our greatest asset. All Synteract employees are carefully selected based upon their experience, talent, integrity and dedication. Our project staff has an average of over eight years of working with research data in both large and small pharmaceutical firms. The team of individuals assigned to your project will be carefully selected. Efficient software solutions, effective processes, and our creative, yet organized, approach allow us to meet your aggressive schedules while maintaining the highest degree of quality. Synteract provides a full range of services to complement your existing resources. As our name implies, in synergy we interact with you, together accomplishing impressive results.
Number of Employees 174
Contact Information
5759 Fleet St Ste 100
Carlsbad, California 92008
1 760 268 8200
Peer Companies
NAICS Code Custom Computer Programming Services: 541511
News & Analysis
Filter by
synteract inc. - All News and Analysis
Synteract Eyes Central Eastern European CRO Office
Wireless News 06-24-2009 Synteract Eyes Central Eastern European CRO Office Type: News Synteract, a full-service contract research organization CRO dedicated to meeting the clinical research, technology, and safety needs of biotechnology, medical device, and pharmaceutical companies, will open a Central Eastern European...
Synteract Plans Central Eastern European CRO Office to Open in August 2009
Clinical Contract Research Organization Expands Global Footprint SAN DIEGO -- Synteract, Inc., a full-service contract research organization CRO ...
Synteract Extends Consulting Services to VCs Funding Biopharmaceutical Start-ups
Wireless News 06-15-2009 Synteract Extends Consulting Services to VCs Funding Biopharmaceutical Start-ups Type: News Synteract, Inc., a contract research organization CRO dedicated to meeting the clinical research, technology, and safety needs of biotechnology, medical device, and pharmaceutical companies, has expanded its consulting...
Synteract Expands Consulting Offerings to VC Funding Biopharmaceutical Start-ups
Wireless News 06-12-2009 Synteract Expands Consulting Offerings to VC Funding Biopharmaceutical Start-ups Type: News Synteract, a full-service contract research organization CRO dedicated to meeting the clinical research, technology, and safety needs of biotechnology, medical device, and pharmaceutical companies, has expanded its consulting...
Synteract Offers Consulting Expertise to Venture Capitalists Funding Biopharmaceutical Start-ups
Clinical Contract Research Organization Provides Incubator Expertise to Mitigate Risk Factors SAN DIEGO -- Synteract, ...
Synteract Offers Free Educational Seminar for Pharmaceutical and Biotech Companies in Southern California
Expertise on CDISC Standards and Legal Representation in the EU Tapped SAN DIEGO -- Synteract, ...
Logo and Branding Refresh with Revised Website Communicate Synteract’s Collaborative Culture and Growth
14-year-old full service CRO introduces Shared Work-Shared Vision branding SAN DIEGO --...
Gryphon Investors Names Susan C. Thornton as President and CEO for Synteract Corporation
SAN FRANCISCO -- Gryphon Investors, a San Francisco-based private equity firm, announced today that Susan C. Thornton, Ph.D., has been named President and CEO of Synteract Corporation, the holding company that owns Synteract, Inc. and Vince & Associates Clinical Research VNA. Synteract Corporation was formed in September, 2008 when Synteract,...
Largest private companies: headquarters located in San Diego County; ranked by 2007 revenue
LARGEST PRIVATE COMPANIES Headquarters located in San Diego County; ranked by 2007 revenue ...
Gryphon Investors Recapitalizes Synteract and Vince & Associates
SAN FRANCISCO -- Gryphon Investors announced today that it led the simultaneous recapitalization of Synteract, Inc. ("Synteract") and Vince & Associates Clinical Research ("VNA") in partnership with management and Celerity Partners. Both Synteract and VNA provide outsourced pharmaceutical services to biotechnology and pharmaceutical companies. The management of Synteract and VNA...
Industry Transcripts by Seeking Alpha
-
Blue Coat Systems, Inc. Q2 2010 Earnings Call Transcript
on Nov 24, 2009about BCSI
-
QAD Inc. F3Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about QADI
-
TiVo Inc. F3Q10 (Qtr End 10/31/2009) Earnings Call Transcript
on Nov 24, 2009about TIVO
-
Brocade Communications Systems Inc. F4Q09 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about BRCD
-
Analog Devices, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 23, 2009about ADI

